BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1058 related articles for article (PubMed ID: 25683490)

  • 61. Effect of IFN-gamma and dexamethasone on TGF-beta1-induced human fetal lung fibroblast-myofibroblast differentiation.
    Gu L; Zhu YJ; Guo ZJ; Xu XX; Xu WB
    Acta Pharmacol Sin; 2004 Nov; 25(11):1479-88. PubMed ID: 15525471
    [TBL] [Abstract][Full Text] [Related]  

  • 62. DIM attenuates TGF-β1-induced myofibroblast differentiation in neonatal rat cardiac fibroblasts.
    Li J; Zhang W; Jiao R; Yang Z; Yuan Y; Wu Q; Hu Z; Xiang S; Tang Q
    Int J Clin Exp Pathol; 2015; 8(5):5121-8. PubMed ID: 26191207
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Protection against TGF-β1-induced fibrosis effects of IL-10 on dermal fibroblasts and its potential therapeutics for the reduction of skin scarring.
    Shi JH; Guan H; Shi S; Cai WX; Bai XZ; Hu XL; Fang XB; Liu JQ; Tao K; Zhu XX; Tang CW; Hu DH
    Arch Dermatol Res; 2013 May; 305(4):341-52. PubMed ID: 23321694
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of tetrandrine on the TGF-β-induced smad signal transduction pathway in human hypertrophic scar fibroblasts in vitro.
    Zunwen L; Shizhen Z; Dewu L; Yungui M; Pu N
    Burns; 2012 May; 38(3):404-13. PubMed ID: 21925794
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Focal adhesion kinase (FAK) siRNA inhibits human hypertrophic scar by suppressing integrin α, TGF-β and α-SMA.
    Chen R; Zhang Z; Xue Z; Wang L; Fu M; Lu Y; Bai L; Zhang D; Fan Z
    Cell Biol Int; 2014 Jul; 38(7):803-8. PubMed ID: 24523242
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of PLAB on apoptosis and Smad signal pathway of hypertrophic scar fibroblasts.
    Cao B; Jiang MC; Lei ZY; Bai SF; Chen H
    J Asian Nat Prod Res; 2008; 10(1-2):147-57. PubMed ID: 18253883
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Loureirin B alleviates cardiac fibrosis by suppressing Pin1/TGF-β1 signaling.
    Cheng M; Yang Z; Li R; Wu G; Zhang C
    Eur J Pharmacol; 2022 Mar; 918():174791. PubMed ID: 35093323
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The anti-scar effects of basic fibroblast growth factor on the wound repair in vitro and in vivo.
    Shi HX; Lin C; Lin BB; Wang ZG; Zhang HY; Wu FZ; Cheng Y; Xiang LJ; Guo DJ; Luo X; Zhang GY; Fu XB; Bellusci S; Li XK; Xiao J
    PLoS One; 2013; 8(4):e59966. PubMed ID: 23565178
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars.
    Zhang ZF; Zhang YG; Hu DH; Shi JH; Liu JQ; Zhao ZT; Wang HT; Bai XZ; Cai WX; Zhu HY; Tang CW
    Burns; 2011 Jun; 37(4):665-72. PubMed ID: 21236582
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Platycodin D inhibits the proliferation and migration of hypertrophic scar-derived fibroblasts and promotes apoptosis through a caspase-dependent pathway.
    Yu Z; Li Y; Fu R; Xue Y; Zhao D; Han D
    Arch Dermatol Res; 2023 Jul; 315(5):1257-1267. PubMed ID: 36526799
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Suppressive effects of human fetal keratinocytes on the proliferation, differentiation and extracellular matrix synthesis of human hypertrophic scar fibroblasts in vitro.
    Wang Z; Song Q; Li H
    Mol Med Rep; 2017 Oct; 16(4):5377-5385. PubMed ID: 28849177
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pirfenidone inhibits transforming growth factor β1-induced extracellular matrix production in nasal polyp-derived fibroblasts.
    Shin JM; Park JH; Park IH; Lee HM
    Am J Rhinol Allergy; 2015; 29(6):408-13. PubMed ID: 26637578
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The inhibitory effect of salvianolic acid B on TGF-β1-induced proliferation and differentiation in lung fibroblasts.
    Zhang M; Cao SR; Zhang R; Jin JL; Zhu YF
    Exp Lung Res; 2014 Apr; 40(4):172-85. PubMed ID: 24669910
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Gallic acid attenuates TGF-β1-stimulated collagen gel contraction via suppression of RhoA/Rho-kinase pathway in hypertrophic scar fibroblasts.
    Hsieh SC; Wu CC; Hsu SL; Feng CH; Yen JH
    Life Sci; 2016 Sep; 161():19-26. PubMed ID: 27457401
    [TBL] [Abstract][Full Text] [Related]  

  • 75. USP15 Enhances the Proliferation, Migration, and Collagen Deposition of Hypertrophic Scar-Derived Fibroblasts by Deubiquitinating TGF-βR1 In Vitro.
    Tu L; Lin Z; Huang Q; Liu D
    Plast Reconstr Surg; 2021 Nov; 148(5):1040-1051. PubMed ID: 34546211
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dehydroabietic acid reverses TNF-α-induced the activation of FOXO1 and suppression of TGF-β1/Smad signaling in human adult dermal fibroblasts.
    Wang XW; Yu Y; Gu L
    Int J Clin Exp Pathol; 2014; 7(12):8616-26. PubMed ID: 25674226
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Botulinum toxin type A suppresses pro-fibrotic effects via the JNK signaling pathway in hypertrophic scar fibroblasts.
    Park GS; An MK; Yoon JH; Park SS; Koh SH; Mauro TM; Cho EB; Park EJ; Kim KH; Kim KJ
    Arch Dermatol Res; 2019 Dec; 311(10):807-814. PubMed ID: 31501922
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Regulation of fibrotic changes by the synergistic effects of cytokines, dimensionality and matrix: Towards the development of an in vitro human dermal hypertrophic scar model.
    Chawla S; Ghosh S
    Acta Biomater; 2018 Mar; 69():131-145. PubMed ID: 29330036
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Galangin inhibits hypertrophic scar formation via ALK5/Smad2/3 signaling pathway.
    Zhang Y; Shan S; Wang J; Cheng X; Yi B; Zhou J; Li Q
    Mol Cell Biochem; 2016 Feb; 413(1-2):109-18. PubMed ID: 26728998
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dermatopontin expression is decreased in hypertrophic scar and systemic sclerosis skin fibroblasts and is regulated by transforming growth factor-beta1, interleukin-4, and matrix collagen.
    Kuroda K; Okamoto O; Shinkai H
    J Invest Dermatol; 1999 May; 112(5):706-10. PubMed ID: 10233760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.